Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin S Murnane

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|April 22, 2024
Deep Brain Stimulation of Nucleus Basalis of Meynert improves learning in rat model of dementiaDeepak Kumbhare, Megan Rajagopal, Jamie Toms, et al.
Behavioral Neuroscience|June 9, 2025
Deep brain stimulation of nucleus basalis of meynert: Effect of stimulation mode and duration on learning in rat model of dementiaDeepak Kumbhare, Megan Rajagopal, Jamie Toms, et al.
Health Psychology Research|September 19, 2022
Methamphetamine Use: A Narrative Review of Adverse Effects and Related ToxicitiesAmber N Edinoff, Sarah E Kaufman, Keionne M Green, et al.
Neuropharmacology|April 17, 2021
α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transportersJulian Maier, Laurin Rauter, Deborah Rudin, et al.
Health Psychology Research|August 1, 2022
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive reviewHannah W Haddad, Garett W Malone, Nicholas J Comardelle, et al.
Irish Journal of Psychological Medicine|November 7, 2024
Amid magic and menace: psychiatrists' attitudes to psilocybin therapyAndrew Gribben, Tara Burke, Colm Harrington, et al.
Frontiers in Psychiatry|April 8, 2026
Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotypeAlexandru Mihai Dumitrescu, M Frances Vest, Annette E Fleckenstein, et al.
Current Pain and Headache Reports|March 20, 2024
Xylazine: A Drug Adulterant of Clinical ConcernAmber N Edinoff, Saveen Sall, William C Upshaw, et al.
Circulation. Arrhythmia and Electrophysiology|December 28, 2021
Stimulant Drugs of Abuse and Cardiac ArrhythmiasPaari Dominic, Javaria Ahmad, Hajra Awwab, et al.
Investigative Ophthalmology & Visual Science|July 2, 2025
Retinal Angiogenesis in Methamphetamine Self-Administration RatsMinsup Lee, Bo J Wood, Hyeon Hak Jeong, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|April 22, 2024
Deep Brain Stimulation of Nucleus Basalis of Meynert improves learning in rat model of dementiaDeepak Kumbhare, Megan Rajagopal, Jamie Toms, et al.
Behavioral Neuroscience|June 9, 2025
Deep brain stimulation of nucleus basalis of meynert: Effect of stimulation mode and duration on learning in rat model of dementiaDeepak Kumbhare, Megan Rajagopal, Jamie Toms, et al.
Health Psychology Research|September 19, 2022
Methamphetamine Use: A Narrative Review of Adverse Effects and Related ToxicitiesAmber N Edinoff, Sarah E Kaufman, Keionne M Green, et al.
Neuropharmacology|April 17, 2021
α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transportersJulian Maier, Laurin Rauter, Deborah Rudin, et al.
Health Psychology Research|August 1, 2022
Aduhelm, a novel anti-amyloid monoclonal antibody, for the treatment of Alzheimer's Disease: A comprehensive reviewHannah W Haddad, Garett W Malone, Nicholas J Comardelle, et al.
Irish Journal of Psychological Medicine|November 7, 2024
Amid magic and menace: psychiatrists' attitudes to psilocybin therapyAndrew Gribben, Tara Burke, Colm Harrington, et al.
Frontiers in Psychiatry|April 8, 2026
Trail Making Test performance in early abstinence from methamphetamine: human evidence for a drug-associated Parkinsonian-like phenotypeAlexandru Mihai Dumitrescu, M Frances Vest, Annette E Fleckenstein, et al.
Current Pain and Headache Reports|March 20, 2024
Xylazine: A Drug Adulterant of Clinical ConcernAmber N Edinoff, Saveen Sall, William C Upshaw, et al.
Circulation. Arrhythmia and Electrophysiology|December 28, 2021
Stimulant Drugs of Abuse and Cardiac ArrhythmiasPaari Dominic, Javaria Ahmad, Hajra Awwab, et al.
Investigative Ophthalmology & Visual Science|July 2, 2025
Retinal Angiogenesis in Methamphetamine Self-Administration RatsMinsup Lee, Bo J Wood, Hyeon Hak Jeong, et al.
Pageof 9